Compare HP & TMDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | HP | TMDX |
|---|---|---|
| Founded | 1920 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.7B | 3.8B |
| IPO Year | 1994 | 2019 |
| Metric | HP | TMDX |
|---|---|---|
| Price | $39.31 | $100.97 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 12 | 9 |
| Target Price | $34.17 | ★ $148.22 |
| AVG Volume (30 Days) | ★ 997.5K | 763.2K |
| Earning Date | 05-06-2026 | 05-05-2026 |
| Dividend Yield | ★ 2.59% | N/A |
| EPS Growth | N/A | ★ 382.18 |
| EPS | N/A | ★ 4.87 |
| Revenue | ★ $3,746,013,000.00 | $605,494,000.00 |
| Revenue This Year | $9.50 | $24.25 |
| Revenue Next Year | $3.34 | $18.75 |
| P/E Ratio | ★ N/A | $22.26 |
| Revenue Growth | 35.89 | ★ 37.13 |
| 52 Week Low | $14.65 | $88.51 |
| 52 Week High | $39.05 | $156.00 |
| Indicator | HP | TMDX |
|---|---|---|
| Relative Strength Index (RSI) | 67.12 | 37.47 |
| Support Level | $32.88 | $97.66 |
| Resistance Level | N/A | $120.60 |
| Average True Range (ATR) | 1.16 | 5.39 |
| MACD | 0.48 | -0.00 |
| Stochastic Oscillator | 94.53 | 1.91 |
Helmerich & Payne Inc provides performance-driven drilling solutions and technologies to make hydrocarbon recovery safer and more economical for oil and gas exploration and production companies. Focusing on the drilling segment, its technology services develop and commercialize solutions that improve drilling efficiency, accuracy, and wellbore quality and placement. The company operates through North America Solutions, International Solutions, and Offshore Solutions segments. The North America segment runs a technologically advanced AC drive drilling rig fleet in the U.S., with a presence in shale and unconventional basins, while the Offshore Solutions segment, operating rigs on fixed-leg and floating platforms, generates the majority of revenue.
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.